نتایج جستجو برای: accrual factor

تعداد نتایج: 846509  

Journal: :Journal of community medicine & health education 2013
Monica Trevino Susan Padalecki Anand Karnad Alberto Parra Steve Weitman Melissa Nashawati Brad H Pollock Amelie Ramirez Ian M Thompson

BACKGROUND Cancer does not occur in all ethnic and racial groups at similar rates. In addition, responses to treatment also vary in certain ethnic and racial groups. For Hispanics, the overall cancer incidence is generally lower yet for some specific tumor types, the incidence rates are higher compared to other populations. OBJECTIVES Although disparities are recognized for treatment outcomes...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2017
Chad Tang Steven I Sherman Mellanie Price Jun Weng Suzanne E Davis David S Hong James C Yao Aman Buzdar George Wilding J Jack Lee

Purpose: Slow-accruing clinical trials delay the translation of basic biomedical research, contribute to increasing health care costs, and may prohibit trials from reaching their original goals.Experimental Design: We analyzed a prospectively maintained institutional database that tracks all clinical studies at the MD Anderson Cancer Center (Houston, TX). Inclusion criteria were activated phase...

2008
Jin Ginger Wu Lu Zhang Stephen M. Ross Frank Zhang

Interpreting accruals as working capital investment, we hypothesize that firms optimally adjust their capital investment in response to discount rate changes. Consistent with the discount-rate hypothesis, we document that (i) the predictive power of accruals for future returns increases with the correlations of accruals with past and current stock returns; (ii) controlling for investment substa...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2010
Steven K Cheng Mary S Dietrich David M Dilts

PURPOSE Postactivation barriers to oncology clinical trial accruals are well documented; however, potential barriers prior to trial opening are not. We investigate one such barrier: trial development time. EXPERIMENTAL DESIGN National Cancer Institute Cancer Therapy Evaluation Program (CTEP)-sponsored trials for all therapeutic, nonpediatric phase I, I/II, II, and III studies activated betwee...

Journal: :International Journal of Accounting & Information Management 2016

Journal: :JNCI Journal of the National Cancer Institute 1988

Journal: :OECD Journal on Budgeting 2006

Journal: :FEBS letters 2013
Tiffany Zee Sören Boller Ildiko Györy Munevver P Makinistoglu Jan P Tuckermann Rudolf Grosschedl Gerard Karsenty

Early B-cell factor 1 (Ebf1) is a transcription factor whose inactivation in all cells results in high bone mass because of an increase in bone formation. This observation suggests Ebf1 may be an inhibitor of osteoblast differentiation. To test this contention, we analyzed Ebf1 pattern of expression and function in osteoblasts ex vivo and in vivo through osteoblast-specific inactivation in the ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید